Cargando…
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Diabetic cardiomyopathy (DCM), although a distinct clinical entity, is also a part of the diabetic atherosclerosis process. It may be independent of the coexistence of ischemic heart disease, hypertension, or other macrovascular complications. Its pathological substrate is characterized by the prese...
Autores principales: | Voulgari, Christina, Papadogiannis, Dimitrios, Tentolouris, Nicholas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964943/ https://www.ncbi.nlm.nih.gov/pubmed/21057575 http://dx.doi.org/10.2147/VHRM.S11681 |
Ejemplares similares
-
The ECG Vertigo in Diabetes and Cardiac Autonomic Neuropathy
por: Voulgari, Christina, et al.
Publicado: (2011) -
A review of nateglinide in the management of patients with type 2 diabetes
por: Tentolouris, Nicholas, et al.
Publicado: (2007) -
Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives
por: Voulgari, Christina, et al.
Publicado: (2009) -
P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction
por: Woo, Sun-Hee, et al.
Publicado: (2020) -
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
por: Cohen, Charles D., et al.
Publicado: (2023)